Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53.9M |
| 2 |
COUP
Coupa Software Incorporated
COUP
|
+$32.1M |
| 3 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$27.8M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$20.1M |
| 5 |
M&T Bank
MTB
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$93.4M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$71.8M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$42.9M |
| 4 |
ZEN
ZENDESK INC
ZEN
|
+$42.3M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$41.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.01% |
| 2 | Financials | 11.75% |
| 3 | Industrials | 10.85% |
| 4 | Healthcare | 10.32% |
| 5 | Consumer Discretionary | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FFWM
626
DELISTED
First Foundation Inc
FFWM
| $2.05M | 0.04% |
142,879
+85,116
| +147% | +$1.32M |
|
627
Pegasystems
PEGA
$5.55B
| $2.05M | 0.04% |
119,592
-90,494
| -43% | -$1.56M |
|
628
Procore
PCOR
$9.43B
| $2.04M | 0.04% |
43,226
-4,050
| -9% | -$207K |
|
|
KCGI
629
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
| $2.04M | 0.04% |
200,000
| – | – |
|
630
Avient
AVNT
$4.06B
| $2.03M | 0.04% |
60,254
-112,236
| -65% | -$3.69M |
|
631
CALL
Genuine Parts
GPC
$18.6B
| $2.03M | 0.04% |
11,700
+5,600
| +92% | +$974K |
|
632
Stratasys
SSYS
$670M
| $2.03M | 0.04% |
171,082
+5,580
| +3% | +$74.4K |
|
633
CALL
C.H. Robinson
CHRW
$16.7B
| $2.02M | 0.04% |
22,100
+11,900
| +117% | +$1.13M |
|
634
Royal Gold
RGLD
$22.1B
| $2.01M | 0.04% |
+17,864
| New | +$1.84M |
|
635
Magnite
MGNI
$3.39B
| $2.01M | 0.04% |
190,016
-159,885
| -46% | -$1.46M |
|
636
Asbury Automotive
ABG
$3.84B
| $2.01M | 0.04% |
11,213
-3,867
| -26% | -$647K |
|
|
SMAR
637
DELISTED
Smartsheet Inc.
SMAR
| $2.01M | 0.04% |
51,063
+16,555
| +48% | +$564K |
|
|
AIMBU
638
DELISTED
Aimfinity Investment Corp I Subunit
AIMBU
| $2.01M | 0.04% |
200,000
| – | – |
|
639
Robinhood
HOOD
$96.8B
| $1.99M | 0.04% |
+244,460
| New | +$2.4M |
|
|
EDR
640
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $1.98M | 0.04% |
87,793
-22,739
| -21% | -$485K |
|
|
CHX
641
DELISTED
ChampionX
CHX
| $1.97M | 0.04% |
+67,942
| New | +$1.88M |
|
642
NovoCure
NVCR
$1.96B
| $1.97M | 0.04% |
+26,855
| New | +$2.02M |
|
643
Advanced Micro Devices
AMD
$750B
| $1.97M | 0.04% |
30,363
-19,821
| -39% | -$1.31M |
|
644
Enova International
ENVA
$6.15B
| $1.96M | 0.04% |
51,125
+30,006
| +142% | +$1.1M |
|
645
CALL
Broadcom
AVGO
$1.72T
| $1.96M | 0.04% |
+35,000
| New | +$1.75M |
|
646
GATX Corp
GATX
$6.24B
| $1.96M | 0.04% |
18,391
-28,917
| -61% | -$3.01M |
|
|
MDRX
647
DELISTED
Veradigm Inc. Common Stock
MDRX
| $1.95M | 0.04% |
110,634
-33,237
| -23% | -$557K |
|
|
NEWR
648
DELISTED
New Relic, Inc.
NEWR
| $1.94M | 0.04% |
+34,360
| New | +$1.94M |
|
649
Shift4
FOUR
$3.85B
| $1.94M | 0.04% |
+34,661
| New | +$1.64M |
|
650
Tetra Tech
TTEK
$9.49B
| $1.93M | 0.04% |
66,555
-29,470
| -31% | -$852K |
|
Similar funds
Paul Tudor Jones's Q4 2022 Portfolio in Review
As of Q4 2022, Paul Tudor Jones held 3,056 positions worth $5.06B, up 9.2% from $4.63B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Paul Tudor Jones deployed $198M of net new capital in Q4 2022, opening 801 new positions and adding to 766 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $39M trimmed.
- Paul Tudor Jones's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
- Paul Tudor Jones added most to Coupa Software Incorporated in Q4 2022, an estimated $32.1M increase.
- Paul Tudor Jones's biggest Q4 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $39M.
- Paul Tudor Jones fully exited Alleghany Corp in Q4 2022, selling an estimated $93.4M.
- Paul Tudor Jones's ten largest holdings make up 9.1% of its $5.06B portfolio in Q4 2022.
- Paul Tudor Jones opened 801 new positions and closed 756 in Q4 2022.
- Paul Tudor Jones's portfolio value rose 9.2% quarter-over-quarter to $5.06B.
Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.